help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwitzgebel, V. M.
Right arrow Articles by Philippe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwitzgebel, V. M.
Right arrow Articles by Philippe, J.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 9 4398-4406
Copyright © 2003 by The Endocrine Society

Agenesis of Human Pancreas due to Decreased Half-Life of Insulin Promoter Factor 1

Valerie M. Schwitzgebel, Aline Mamin, Thierry Brun, Beate Ritz-Laser, Maia Zaiko, Alexandre Maret, Francois R. Jornayvaz, Gerald E. Theintz, Olivier Michielin, Danielle Melloul and Jacques Philippe

Pediatric Endocrinology and Diabetology (V.M.S.) and Diabetes Unit (A.M., T.B., B.R.-L., M.Z., J.P.), Geneva University Hospital, CH-1211 Geneva, Switzerland; Pediatric Endocrinology and Diabetology, Lausanne University Hospital (A.M., F.R.J., G.E.T.), CH-1011 Lausanne, Switzerland; Ludwig Institute for Cancer Research (O.M.) and Swiss Institute for Bioinformatics (O.M.), CH-1066 Epalinges, Switzerland; and Department of Endocrinology and Metabolism, Hebrew University Hadassah Medical Center (D.M.), 91120 Jerusalem, Israel

Address all correspondence and requests for reprints to: Dr. Valérie M. Schwitzgebel, Pediatric Endocrinology and Diabetology, Hôpital des Enfants, 6 rue Willy Donzé, CH-1211 Geneva, Switzerland. E-mail: valerie.schwitzgebel{at}medcli.unige.ch.

Neonatal diabetes mellitus can be transient or permanent. The severe form of permanent neonatal diabetes mellitus can be associated with pancreas agenesis. Normal pancreas development is controlled by a cascade of transcription factors, where insulin promoter factor 1 (IPF1) plays a crucial role. Here, we describe two novel mutations in the IPF1 gene leading to pancreas agenesis. Direct sequence analysis of exons 1 and 2 of the IPF1 gene revealed two point mutations within the homeobox in exon 2. Genetic analysis of the parents showed that each mutation was inherited from one parent. Mutations localized in helixes 1 and 2, respectively, of the homeodomain, decreased the protein half-life significantly, leading to intracellular IPF1 levels of 36% and 27% of wild-type levels. Both mutant forms of IPF1 were normally translocated to the nucleus, and their DNA binding activity on different known target promoters was similar to that of the wild-type protein. However, transcriptional activity of both mutant IPF1 proteins, alone or in combination with HNF3ß/Foxa2, Pbx1, or the heterodimer E47-ß2 was reduced, findings accounted for by decreased IPF1 steady state levels and not by impaired protein-protein interactions. We conclude that the IPF1 level is critical for human pancreas formation.

This work was supported by a grant from the Swiss National Science Foundation.

Abbreviations: aa, Amino acids; BHK, baby hamster kidney; CAT, chloramphenicol acetyl transferase; GFP, green fluorescent protein; GST, glutathione-S-transferase; HB-EGF, heparin-binding epidermal growth factor; HEK, human embryonic kidney; IPF1, insulin promoter factor 1; ND, neonatal diabetes mellitus; PAP, placental-alkaline phosphatase; PDX1, pancreatic duodenal homeobox factor 1.




This article has been cited by other articles:


Home page
PediatricsHome page
R. Chen, K. Hussain, M. Al-Ali, M. T. Dattani, P. Hindmarsh, P. M. Jones, and P. Marsh
Neonatal and Late-Onset Diabetes Mellitus Caused by Failure of Pancreatic Development: Report of 4 More Cases and a Review of the Literature
Pediatrics, June 1, 2008; 121(6): e1541 - e1547.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Aguilar-Bryan and J. Bryan
Neonatal Diabetes Mellitus
Endocr. Rev., May 1, 2008; 29(3): 265 - 291.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. C. Jorgensen, J. Ahnfelt-Ronne, J. Hald, O. D. Madsen, P. Serup, and J. Hecksher-Sorensen
An Illustrated Review of Early Pancreas Development in the Mouse
Endocr. Rev., October 1, 2007; 28(6): 685 - 705.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Suzuki, Y. Makita, T. Mukai, K. Matsuo, O. Ueda, and K. Fujieda
Molecular Basis of Neonatal Diabetes in Japanese Patients
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3979 - 3985.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. O. Wiebe, J. D. Kormish, V. T. Roper, Y. Fujitani, N. I. Alston, K. S. Zaret, C. V. E. Wright, R. W. Stein, and M. Gannon
Ptf1a Binds to and Activates Area III, a Highly Conserved Region of the Pdx1 Promoter That Mediates Early Pancreas-Wide Pdx1 Expression
Mol. Cell. Biol., June 1, 2007; 27(11): 4093 - 4104.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Chen, H.-X. Yan, J. Chen, W. Yang, Q. Liu, B. Zhai, H.-F. Cao, S.-Q. Liu, M.-C. Wu, and H.-Y. Wang
Negative Regulation of c-Myc Transcription by Pancreas Duodenum Homeobox-1
Endocrinology, May 1, 2007; 148(5): 2168 - 2180.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Eto, V. Kaur, and M. K. Thomas
Regulation of Pancreas Duodenum Homeobox-1 Expression by Early Growth Response-1
J. Biol. Chem., March 2, 2007; 282(9): 5973 - 5983.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. S. Slingerland and A. T. Hattersley
Activating Mutations in the Gene Encoding Kir6.2 Alter Fetal and Postnatal Growth and Also Cause Neonatal Diabetes
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2782 - 2788.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. C. Koster, M. A. Permutt, and C. G. Nichols
Diabetes and Insulin Secretion: The ATP-Sensitive K+ Channel (KATP) Connection
Diabetes, November 1, 2005; 54(11): 3065 - 3072.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. V. Sagen, H. Raeder, E. Hathout, N. Shehadeh, K. Gudmundsson, H. Baevre, D. Abuelo, C. Phornphutkul, J. Molnes, G. I. Bell, et al.
Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2: Patient Characteristics and Initial Response to Sulfonylurea Therapy
Diabetes, October 1, 2004; 53(10): 2713 - 2718.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. R. Gauthier, T. Brun, E. J. Sarret, H. Ishihara, O. Schaad, P. Descombes, and C. B. Wollheim
Oligonucleotide Microarray Analysis Reveals PDX1 as an Essential Regulator of Mitochondrial Metabolism in Rat Islets
J. Biol. Chem., July 23, 2004; 279(30): 31121 - 31130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society